Clinical Trial Update: Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 trial investigated carboplatin plus gemcitabine in elderly patients with stage IV non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: NSCLC | Phase 1, Phase 2 | Status: COMPLETED